NCT00054548View on ClinicalTrials.gov

Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

May 31, 2008

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

oblimersen sodium

Given IV

DRUG

paclitaxel

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

OTHER

pharmacological study

Correlative studies

Trial Locations (1)

53792

University of Wisconsin Hospital and Clinics, Madison

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00054548 - Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter